(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AULIVIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

AULIVIN

ST13

US500000079346361

Class

5

Filing

79346361

Registration

7147546

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

08/06/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/22/2022

Registration date

08/29/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/29/2023

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

CN

Examiner

GIBBONS, BRIAN R

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SinoCellTech Ltd.

Representatives

Michael W. Piper Conley Rose, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; medicines for human purposepharmaceutical preparations for the treatment of genetic and immune system diseases and disorderscancerophthalmic diseases and conditionsinfectious diseases; biological preparations for the treatment of cancer; biological preparationspharmaceutical preparations for the treatment of genetic and immune system diseases and disorderscancerophthalmic diseases and conditionsinfectious diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood for medical purposes

Publications

History of USPTO decisions and trademark events.

35 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/05/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/05/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/05/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/26/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/04/2023

FIMP

FINAL DISPOSITION PROCESSED

12/04/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/29/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/29/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/29/2023

GPNX

NOTIFICATION PROCESSED BY IB

06/13/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/13/2023

PUBO

PUBLISHED FOR OPPOSITION

06/13/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/24/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/24/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/24/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/02/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/02/2023

GNFR

FINAL REFUSAL E-MAILED

03/02/2023

CNFR

FINAL REFUSAL WRITTEN

03/02/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/17/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/09/2023

RFNP

REFUSAL PROCESSED BY IB

10/03/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/10/2022

RFRR

REFUSAL PROCESSED BY MPU

09/09/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/19/2022

CNRT

NON-FINAL ACTION WRITTEN

08/18/2022

DOCK

ASSIGNED TO EXAMINER

08/16/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/29/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/28/2022

Continuous trademark protection

Get notified about every new filing that threatens AULIVIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.